Aclacinomycin A and etoposide (VP-16-213): an effective regimen in previously treated patients with refractory acute myelogenous leukemia.
Aclacinomycin A and etoposide (VP-16-213): an effective regimen in previously treated patients with refractory acute myelogenous leukemia.
复制标题
阿克拉霉素 A 和依托泊苷 (VP-16-213)：对于既往治疗过的难治性急性髓性白血病患者来说是一种有效的治疗方案。
作者：
Rowe,JM;Chang,AY;Bennett,JM
